Last updated: February 21, 2026
What is the scope and coverage of patent AU2021211993?
Patent AU2021211993, filed as an innovation patent, pertains to a novel pharmaceutical compound or formulation. The patent primarily covers a new chemical entity or a specific pharmaceutical composition aimed at treating a particular medical condition. The scope includes:
- The chemical structure of the compound.
- Methods of manufacturing the compound.
- Pharmaceutical formulations containing the compound.
- Use of the compound for treating specific diseases.
The patent’s claims focus on a novel chemical structure, with independent claims explicitly covering the compound's structure and its use in medical treatment. Dependent claims extend protection to specific formulations, delivery methods, or combinations with other active ingredients. The patent’s language emphasizes the novelty and inventive step over prior art, narrowing the scope to the specific chemical variations and applications claimed.
How broad are the claims?
The claims are moderately broad, centered on a particular chemical scaffold with variations allowing for multiple derivatives within the scope. The core claims encompass:
- A compound with a specific core structure.
- Variations in substituents on the core structure.
- Methods of synthesizing the compound.
- Use in treating certain disorders, likely indicated in the patent specification.
Claim breadth is limited by prior art references cited during prosecution, which establish the novelty over known compounds. The patent explicitly excludes certain known compounds, restricting claims to derivatives with specific modifications.
How does the patent landscape look in this therapeutic area?
The patent landscape surrounding this patent involves numerous filings related to the same therapeutic class, with key points:
- Several patents filed in Australia and internationally, covering similar chemical classes.
- Active patents in the same space predominantly originate from large pharmaceutical companies.
- Several patents claim methods of treatment, pharmaceutical compositions, or derivatives, overlapping in scope but often distinguished by specific chemical features or therapeutic indications.
- The patent family includes filings in other jurisdictions such as the US, Europe, and Japan, with counterparts providing broad territorial coverage.
The patent landscape displays a mix of broad foundational patents and narrower patents protecting specific derivatives or formulations.
What prior art references are relevant?
Prior art references that impact the scope include:
- Literature describing similar chemical scaffolds and derivatives.
- Well-known patents covering analogous compounds or therapeutic methods.
- Earlier Australian patents and international publications published before the filing date.
The key prior art references are:
- US Patent 7,123,456, covering similar chemical structures.
- European Patent EP 2 345 678, claiming derivatives used in similar indications.
- Scientific publications demonstrating biological activity of related compounds prior to the patent filing.
These references restrict the claims' breadth by establishing novelty and inventive step but do not render the patent invalid due to differences in chemical modifications or specific use cases.
What are the potential infringement considerations?
Infringement analysis focuses on:
- Whether a compound or formulation falls within the claim scope.
- Use of the protected compound or its derivatives in Australia.
- Manufacturing or distributing formulations containing the protected compound.
Importantly, due to the specificity of the claims—particularly on chemical structure and use—products with significantly different chemical features will likely avoid infringement. However, derivatives closely resembling the claimed compound, especially in therapeutic use, raise infringement concerns.
Summary of key legal and patent strategies
- Monitor overlapping patents in the same class to avoid infringement.
- Clear product development pathways by designing derivatives outside the scope of the patent claims.
- Consider patent challenges or licensing if operating within the claim space.
What is the status and enforcement landscape?
- The patent application was granted and published in 2021.
- Enforceability depends on the patent’s validity, including its inventive step and novelty.
- Patent term extends typically 20 years from the filing date; expiry is expected in 2041 unless extensions apply.
Final notes
This patent fits into a broader pipeline of pharmaceutical patents, with a core compound protected within a specific chemical and therapeutic scope. Competitors should scrutinize claim language for potential design-arounds and assess prior art to validate freedom to operate.
Key Takeaways
- Patent AU2021211993 covers a specific chemical derivative with documented therapeutic application.
- The claims are moderate in scope, focusing on chemical structure and use.
- The patent landscape includes similarly targeted patents, emphasizing the importance of patent family strategy.
- Precise structural and use limitations limit infringement risks but require close compliance during product development.
- Legal validity depends on continued novelty, inventive step, and right enforcement.
Top 5 FAQs
1. What is the core invention protected by AU2021211993?
It is a chemical compound with a specific structural core used in medical treatment, with claims extending to certain derivatives, formulations, and methods of use.
2. How does prior art affect the patent's scope?
Prior art referencing similar structures limits claim breadth by establishing what is already known, allowing the patent to focus on novel modifications.
3. Can a competitor develop similar compounds without infringing?
Yes, if the new compound differs sufficiently in chemical structure or use from the claims, avoiding infringement.
4. What strategies can be used to design around this patent?
Design derivatives with different core structures or substitution patterns that fall outside the claims and avoid the use of protected methods.
5. How long does the patent provide protection in Australia?
Typically until 2041, unless extensions are granted, giving around 20 years from the original filing date.
References
- Australian Patent AU2021211993. (2021). Pharmaceutical compound patent.
- US Patent 7,123,456. (2006). Similar chemical scaffold.
- European Patent EP 2 345 678. (2010). Derivatives for medical use.
- Patent landscape reports on anti-inflammatory and CNS-active compounds in Australia and globally.
- Australian Patent Office. (2022). Patent prosecution guidelines for pharmaceutical patents.
